... In 2007, Ropren was approved by the Russian Ministry of Health for entry into the Russian Pharmacopoeia as an ... and normalise cholesterol levels, as well as alleviate the symptoms of neurodegenerative disorders (including Alzheimer’s disease, Parkinson's disease ... , Australia, reported in 2006, confirmed certain neurocognitive effects of Ropren identified previously in Russia. High potency Ropren is ...